Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02708524 · ClinicalTrials.gov registry record · NA

Clinical Study of Approved and Investigational Contact Lenses

A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
554
Enrollment target
18
Study locations

NCT02708524 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 554 participants, above the 112-participant average among 20 other Visual Acuity trials with a reported enrollment target (395% higher). The trial reports 18 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02708524, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
554 participants
Enrollment target
18
Study locations

Study Summary

This is a multi-site, 5-visit, double-masked, dispensing study comparing an investigational contact lens with currently-marketed contact lenses. The objective of the study is to evaluate the comfort of the lenses when worn for 30 (-2/+6) days on daily wear modality.

Conditions Studied

Interventions

  • DEVICE Senofilcon C Contact Lens
  • DEVICE Comfilcon A Contact Lens
  • DEVICE Lotrafilcon B Contact Lens
  • DEVICE Samfilcon A Contact Lens

Study Locations (18)

Florida

  • - Fruit Cove
  • - Jacksonville
  • - Jacksonville
  • - Longwood
  • - Tallahassee
  • - Tampa

Alabama

  • - Montgomery

Georgia

  • - Roswell

Illinois

  • - Bloomington

Michigan

  • - East Lansing

Minnesota

  • - Medina

New Jersey

  • - Closter

New York

  • - Vestal

Trial Details

FieldValue
Enrollment Target 554 participants
Start Date 2016-01
Est. Completion 2016-03
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT02708524

The ClinicalTrials.gov registry entry for NCT02708524 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 554 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 112-participant average among 20 other Visual Acuity trials with a reported enrollment target (395% higher). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 4 interventions - of which Senofilcon C Contact Lens is the first listed.

NCT02708524 reports 18 study locations spanning 13 distinct geographic areas - top geographies include Florida, Alabama, Georgia.

Frequently Asked Questions

What is clinical trial NCT02708524 about?

NCT02708524 is a clinical study titled "Clinical Study of Approved and Investigational Contact Lenses". This is a multi-site, 5-visit, double-masked, dispensing study comparing an investigational contact lens with currently-marketed contact lenses. The objective of the study is to evaluate the comfort of the lenses when worn for 30 (-2/+6) days on daily wear modality.

What is the current status of trial NCT02708524?

This trial is currently completed. It is a NA study. The enrollment target is 554 participants. The study started on 2016-01. Estimated completion is 2016-03.

What conditions does trial NCT02708524 study?

This clinical trial studies the following conditions: Visual Acuity.

What interventions are being tested in trial NCT02708524?

The interventions under investigation include: Senofilcon C Contact Lens (DEVICE), Comfilcon A Contact Lens (DEVICE), Lotrafilcon B Contact Lens (DEVICE), Samfilcon A Contact Lens (DEVICE).

Who is sponsoring clinical trial NCT02708524?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02708524 being conducted?

This trial has 18 study locations across Alabama, Florida, Georgia, Illinois, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Visual Acuity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.